{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:23:47Z","timestamp":1790663027169,"version":"4.1.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Detailed analyses of genetic diversity, antigenic variability, protein localization and immunological responses are vital for the prioritization of novel malaria vaccine candidates. Comprehensive approaches to determine the most appropriate antigen variants needed to provide broad protection are challenging and consequently rarely undertaken.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we characterized PF3D7_1136200, which we named Asparagine-Rich Merozoite Antigen (ARMA) based on the analysis of its sequence, localization and immunogenicity. We analyzed IgG and IgM responses against the common variants of ARMA in independent prospective cohort studies in Burkina Faso (N = 228), Kenya (N = 252) and Mali (N = 195) using a custom microarray, Div-KILCHIP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found a marked population structure between parasites from Africa and Asia. African isolates shared 34 common haplotypes, including a dominant pair although the overall selection pressure was directional (Tajima\u2019s D = -2.57; Fu and Li\u2019s F = -9.69; P &amp;lt; 0.02). ARMA was localized to the merozoite surface, IgG antibodies induced Fc-mediated degranulation of natural killer cells and strongly inhibited parasite growth in vitro. We found profound serological diversity, but IgG and IgM responses were highly correlated and a hierarchical clustering analysis identified only three major serogroups. Protective IgG and IgM antibodies appeared to target both cross-reactive and distinct epitopes across variants. However, combinations of IgG and IgM antibodies against selected variants were associated with complete protection against clinical episodes of malaria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our systematic strategy exploits genomic data to deduce the handful of antigen variants with the strongest potential to induce broad protection and may be broadly applicable to other complex pathogens for which effective vaccines remain elusive.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1156806","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:19:21Z","timestamp":1681449561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of a novel Plasmodium falciparum merozoite surface antigen and potential vaccine target"],"prefix":"10.3389","volume":"14","author":[{"given":"Karamoko","family":"Niar\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Chege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy","family":"Mwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Sa\u00dfmannshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Odera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nyamako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tuju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiono","family":"Alfred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Waitumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhards","family":"Ogutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiomon B.","family":"Sirima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Awandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bourema","family":"Kouriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian C.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith H. A.","family":"Osier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"B1","unstructured":"World malaria report 20212021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: A systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30282-8","article-title":"Malaria vaccination and rebound malaria","volume":"19","author":"Dicko","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001685","article-title":"Efficacy and safety of the RTS,S\/AS01 malaria vaccine during 18 months after vaccination: A phase 3 randomized, controlled trial in children and young infants at 11 African sites","volume":"11","year":"2014","journal-title":"PloS Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00576-10","article-title":"Allelic diversity and naturally acquired allele-specific antibody responses to plasmodium falciparum apical membrane antigen 1 in Kenya","volume":"78","author":"Osier","year":"2010","journal-title":"Infect Immun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1086\/339342","article-title":"A recombinant blood-stage malaria vaccine reduces plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua new Guinea","volume":"185","author":"Genton","year":"2002","journal-title":"J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1038\/s41598-020-60551-z","article-title":"Microarray analyses reveal strain-specific antibody responses to plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination","volume":"10","author":"Bailey","year":"2020","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4269\/ajtmh.14-0140","article-title":"Short report: Seroreactivity to a large panel of field-derived plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria","volume":"92","author":"Bailey","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the ab response to plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02866","article-title":"KILchip v1.0: A novel plasmodium falciparum merozoite protein microarray to facilitate malaria vaccine candidate prioritization","volume":"9","author":"Kamuyu","year":"2018","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv224","article-title":"Plasmodium falciparum protein microarray antibody profiles correlate with protection from symptomatic malaria in Kenya","volume":"212","author":"Dent","year":"2015","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.081695","article-title":"Profiling the antibody immune response against blood stage malaria vaccine candidates","volume":"53","author":"Gray","year":"2007","journal-title":"Clin Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(73)90468-3","article-title":"Enzymatic end-to-end joining of DNA molecules","volume":"78","author":"Lobban","year":"1973","journal-title":"J Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(77)90039-3","article-title":"Protein expression in e. coli minicells by recombinant plasmids","volume":"10","author":"Meagher","year":"1977","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/275617a0","article-title":"Phenotypic expression in e. coli of a DNA sequence coding for mouse dihydrofolate reductase","volume":"275","author":"Chang","year":"1978","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.O113.028357","article-title":"A library of functional recombinant cell-surface and secreted p. falciparum merozoite proteins","volume":"12","author":"Crosnier","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"247ra102","DOI":"10.1126\/scitranslmed.3008705","article-title":"New antigens for a multicomponent blood-stage malaria vaccine","volume":"6","author":"Osier","year":"2014","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M600035-MCP200","article-title":"Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite plasmodium falciparum","volume":"5","author":"Gilson","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2958.2009.07026.x","article-title":"New insights into the blood-stage transcriptome of plasmodium falciparum using RNA-seq","volume":"76","author":"Otto","year":"2010","journal-title":"Mol Microbiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.chom.2018.03.007","article-title":"Chromatin accessibility-based characterization of the gene regulatory network underlying plasmodium falciparum blood-stage development","volume":"23","author":"Toenhake","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/1755-0998.12549","article-title":"Vcfr : a package to manipulate and visualize variant call format data in r","volume":"17","author":"Knaus","year":"2017","journal-title":"Mol Ecol Resour"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B28","volume-title":"Evolution and the genetics of populations","author":"Wright","year":"1984"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/genetics\/123.3.585","article-title":"Statistical method for testing the neutral mutation hypothesis by DNA polymorphism","volume":"123","author":"Tajima","year":"1989","journal-title":"Genetics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/genetics\/133.3.693","article-title":"Statistical tests of neutrality of mutations","volume":"133","author":"Fu","year":"1993","journal-title":"Genetics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/2041-210X.12410","article-title":"Popart : full-feature software for haplotype network construction","volume":"6","author":"Leigh","year":"2015","journal-title":"Methods Ecol Evol"},{"key":"B32","article-title":"An introduction to information theory","volume":"35","author":"Reza","year":"1994","journal-title":"Dover"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: Molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4939-9550-9_6","article-title":"Serological profiling for malaria surveillance using a standard ELISA protocol","volume":"2013","author":"Murungi","year":"2019","journal-title":"Methods Mol Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn5993","article-title":"Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria","volume":"15","author":"Odera","year":"2023","journal-title":"Sci Transl Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e4708","DOI":"10.1371\/journal.pone.0004708","article-title":"Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya","volume":"4","author":"Ogutu","year":"2009","journal-title":"PloS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.50.529","article-title":"Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya","volume":"50","author":"Beier","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e50036","DOI":"10.1371\/journal.pone.0050036","article-title":"Malaria morbidity in high and seasonal malaria transmission area of Burkina Faso","volume":"8","author":"Ou\u00e9draogo","year":"2013","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.054","article-title":"Incidence of severe plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in bandiagara, Mali","volume":"16","author":"Lyke","year":"2004","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2002.67.604","article-title":"Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in bandiagara, Mali","volume":"67","author":"Coulibaly","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","volume":"18","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1038\/s41467-022-31640-6","article-title":"Phagocytosis of plasmodium falciparum ring-stage parasites predicts protection against malaria","volume":"13","author":"Musasia","year":"2022","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1741-7007-8-76","article-title":"A rapid and scalable method for selecting recombinant mouse monoclonal antibodies","volume":"8","author":"Crosnier","year":"2010","journal-title":"BMC Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit plasmodium falciparum invasion of erythrocytes andare associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009871","article-title":"Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies","volume":"5","author":"Joos","year":"2010","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2016.09.005","article-title":"Cord blood IgG and the risk of severe plasmodium falciparum malaria in the first year of life","volume":"47","author":"Murungi","year":"2017","journal-title":"Int J Parasitol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (MosquirixTM) : An overview","author":"Laurens","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008497","article-title":"Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, plasmodium falciparum","volume":"4","author":"Barry","year":"2009","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e08714","DOI":"10.7554\/eLife.08714","article-title":"Genomic epidemiology of artemisinin resistant malaria","volume":"5","year":"2016","journal-title":"Elife"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nature11174","article-title":"Analysis of plasmodium falciparum diversity in natural infections by deep sequencing","volume":"487","author":"Manske","year":"2013","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.12688\/wellcomeopenres.16168.1","article-title":"An open dataset of plasmodium falciparum genome variation in 7,000 worldwide samples","volume":"6","author":"Ahouidi","year":"2021","journal-title":"Wellcome Open Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.176","article-title":"Phase ia clinical evaluation of the plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors","volume":"19","author":"Sheehy","year":"2011","journal-title":"Mol Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"ofv118","DOI":"10.1093\/ofid\/ofv118","article-title":"Genetic resistance to malaria is AssociatedWith greater enhancement of immunoglobulin (Ig)M than IgG responses to a broad array of plasmodium falciparum antigens","volume":"2","author":"Arama","year":"2015","journal-title":"Ofid"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.09.007","article-title":"Processing of plasmodium falciparum merozoite surface protein MSP1 activates a spectrin-binding function enabling parasite egress from RBCs","volume":"18","author":"Das","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(92)90228-C","article-title":"Secondary processing of the plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1","volume":"50","author":"Blackman","year":"1992","journal-title":"Mol Biochem Parasitol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-6851(01)00336-X","article-title":"The 22 kDa component of the protein complex on the surface of plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7","volume":"117","author":"Pachebat","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2009.03.012","article-title":"Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils","volume":"166","author":"Adda","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e36806","DOI":"10.7554\/eLife.36806","article-title":"NK cells inhibit plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity","volume":"7","author":"Arora","year":"2018","journal-title":"Elife"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.medj.2021.10.003","article-title":"Delayed fractional dosing with RTS,S\/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies","volume":"2","author":"Das","year":"2021","journal-title":"Med (N Y)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01585-07","article-title":"Breadth and magnitude of antibody responses to multiple plasmodium falciparum merozoite antigens are associated with protection from clinical malaria","volume":"76","author":"Osier","year":"2008","journal-title":"Infect Immun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.0141-9838.2004.00705.x","article-title":"Natural antibody response to plasmodium falciparum exp-1, MSP-3 and GLURP long synthetic peptides and association with protection","volume":"26","author":"Meraldi","year":"2004","journal-title":"Parasite Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1475-2875-7-142","article-title":"Cohort study of the association of antibody levels to AMA1, MSP1 19, MSP3 and GLURP with protection from clinical malaria in ghanaian children","volume":"7","author":"Dodoo","year":"2008","journal-title":"Malar J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1086\/656413","article-title":"Association between naturally acquired antibodies to erythrocyte-binding antigens of plasmodium falciparum and protection from malaria and high-density parasitemia","volume":"51","author":"Richards","year":"2010","journal-title":"Clin Infect Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4489","article-title":"IgM in human immunity to plasmodium falciparum malaria","volume":"5","author":"Boyle","year":"2019","journal-title":"Sci Adv"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0232786","DOI":"10.1371\/journal.pone.0232786","article-title":"Dynamics of IgM and IgG responses to the next generation of engineered Duffy binding protein II immunogen: Strain-specific and strain-transcending immune responses over a nine-year period","volume":"15","author":"Medeiros","year":"2020","journal-title":"PloS One"},{"key":"B68","article-title":"Activation and regulation of the first complement component","volume":"42","author":"Cooper","year":"1983","journal-title":"Fed Proc"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/80886","article-title":"Fc\u03b1\/\u03bc receptor mediates endocytosis of IgM-coated microbes","volume":"1","author":"Shibuya","year":"2000","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01708-08","article-title":"Initial b-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin m (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J Virol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1086\/591467","article-title":"Virus and antibody dynamics in acute West Nile virus infection","volume":"198","author":"Busch","year":"2008","journal-title":"J Infect Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.06.014","article-title":"Somatically hypermutated plasmodium-specific IgM+ memory b cells are rapid, plastic, early responders upon malaria rechallenge","volume":"45","author":"Krishnamurty","year":"2016","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-3024.2009.01178.x","article-title":"Allele-specific antibodies to plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria","volume":"32","author":"Osier","year":"2010","journal-title":"Parasite Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav5427","article-title":"Major subpopulations of Plasmodium falciparum in sub-Saharan Africa","volume":"365","author":"Amambua-Ngwa","year":"2019","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2624","article-title":"Multiple populations of artemisinin-resistant plasmodium falciparum in Cambodia","volume":"45","author":"Miotto","year":"2013","journal-title":"Nat Genet"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1156806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T05:19:26Z","timestamp":1681449566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1156806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2023.1156806"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1156806","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"article-number":"1156806"}}